Search for: "Pharmaceutical Generic Developers, Inc."
Results 61 - 80
of 1,121
Sorted by Relevance
|
Sort by Date
24 Jul 2011, 1:21 pm
Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
3 Apr 2024, 1:07 pm
Both brand name and generic pharmaceutical and medical device manufacturers should be aware of these developments. [read post]
23 Oct 2006, 7:42 pm
In In Re Pennington Seed, Inc. [read post]
4 Dec 2023, 10:00 pm
§ 112(a) as it relates to biotechnology and specifically antibody claims, addressed by the Supreme Court in Amgen Inc. v. [read post]
21 Oct 2014, 12:00 am
In Novartis AG v Generics (UK) Limited (t/a Mylan) [2012] EWCA Civ1623, discussed by the IPKat (see here) the Court of Appeal had to review the decision of Floyd J (here) in assessing inventive step where the compound went through several steps during research and development. [read post]
13 Aug 2009, 1:38 pm
Under the terms of the partnership, all intellectual property developed during the JDA will be owned by BP, with an exclusive license to Martek for application and commercialization in nutrition, cosmetic, and pharmaceutical applications. [read post]
28 May 2007, 8:21 pm
VP & Chief IP Counsel, Allergan, Inc. and author of The Generic Challenge) and Robert C. [read post]
24 Nov 2010, 4:31 pm
Manufacturer Xanodyne Pharmaceuticals Inc. has agreed to the ban, and the FDA is asking the manufacturers of generic versions of the drugs to stop selling them. [read post]
10 Oct 2011, 10:00 am
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
23 Oct 2015, 1:52 pm
Imprimis Pharmaceuticals Inc. ... said Thursday it will supply capsules containing Daraprim's active ingredients, pyrimethamine and leucovorin, for $99 for a 100-capsule bottle"Now that's a bargain! [read post]
22 Aug 2013, 1:34 pm
The Zarah and Vestura oral contraceptives are made by Watson Pharmaceuticals, which is now known as Actavis, Inc. [read post]
14 Dec 2010, 6:12 pm
One products liability lawsuit was originally filed by Gladys Mensing, who is suing Teva Pharmaceutical Industries Ltd., Mylan Inc., and Actavis Group. [read post]
27 Nov 2013, 6:00 am
Actavis, Inc., along with its wholly owned subsidiaries Actavis Pharma and Watson Laboratories, (collectively, "Actavis") are pharmaceutical companies that develop, manufacture, market and distribute generic pharmaceutical products for sale in the United States. [read post]
18 Nov 2008, 10:40 pm
Lilly also sued Sandoz Inc., Impax Laboratories Inc. and Cobalt Laboratories Inc. in separate lawsuits for seeking generic approval for Cymbalta tablets. [read post]
2 Oct 2020, 7:50 am
The problem with pharmaceutical and biotech investments such as Ocera Therapeutics Inc. is that they typically involve a high degree of risk. [read post]
7 Sep 2008, 2:47 pm
The outcome as a result of the September 2007 settlement was that hip and knee device manufacturers Zimmer, Inc., DePuy Orthopaedics, Inc. [read post]
20 Feb 2011, 9:21 pm
The lawsuit has named Pharmaceutical Associates Inc., its parent company Beach Products Inc. and Morton Grove Pharmaceuticals Inc. as defendants in the lawsuit. [read post]
3 Mar 2019, 12:38 pm
Teva Pharmaceuticals USA, Inc., Docket No. 17-1229, J. [read post]
6 Jul 2011, 7:23 pm
However, the agency did not order a black box warning for Reglan and its generics until 2009, several years after the plaintiffs developed TD. [read post]
30 Jan 2014, 10:36 am
Lilly is engaged in the business of research, development, manufacture and sale of pharmaceutical products worldwide. [read post]
